1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Necrotizing Fasciitis (NF) Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Necrotizing Fasciitis (NF) Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Penicillin G 1.4.3 Clindamycin 1.4.4 Aminoglycoside 1.4.5 Carbapenem 1.4.6 Metronidazole 1.4.7 Fluoroconazoles 1.4.8 Others 1.5 Market by Application 1.5.1 Global Necrotizing Fasciitis (NF) Treatment Market Size Growth Rate by Application: 2020 VS 2026 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.5.5 Others 1.6 Coronavirus Disease 2019 (Covid-19): Necrotizing Fasciitis (NF) Treatment Industry Impact 1.6.1 How the Covid-19 is Affecting the Necrotizing Fasciitis (NF) Treatment Industry 1.6.1.1 Necrotizing Fasciitis (NF) Treatment Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Necrotizing Fasciitis (NF) Treatment Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Necrotizing Fasciitis (NF) Treatment Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trend 2.1 Global Necrotizing Fasciitis (NF) Treatment Market Perspective (2015-2026) 2.2 Necrotizing Fasciitis (NF) Treatment Growth Trends by Regions 2.2.1 Necrotizing Fasciitis (NF) Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Necrotizing Fasciitis (NF) Treatment Historic Market Size by Regions (2015-2020) 2.2.3 Necrotizing Fasciitis (NF) Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Necrotizing Fasciitis (NF) Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Necrotizing Fasciitis (NF) Treatment Players (Opinion Leaders) 3 Competitor Landscape by Key Players 3.1 Global Top Necrotizing Fasciitis (NF) Treatment Players by Market Size 3.1.1 Global Top Necrotizing Fasciitis (NF) Treatment Players by Revenue (2015-2020) 3.1.2 Global Necrotizing Fasciitis (NF) Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Necrotizing Fasciitis (NF) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Necrotizing Fasciitis (NF) Treatment Market Concentration Ratio 3.2.1 Global Necrotizing Fasciitis (NF) Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 5 and Top 10 Players by Necrotizing Fasciitis (NF) Treatment Revenue in 2019 3.3 Necrotizing Fasciitis (NF) Treatment Key Players Head office and Area Served 3.4 Key Players Necrotizing Fasciitis (NF) Treatment Product Solution and Service 3.5 Date of Enter into Necrotizing Fasciitis (NF) Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Global Necrotizing Fasciitis (NF) Treatment Breakdown Data by Type (2015-2026) 4.1 Global Necrotizing Fasciitis (NF) Treatment Historic Market Size by Type (2015-2020) 4.2 Global Necrotizing Fasciitis (NF) Treatment Forecasted Market Size by Type (2021-2026) 5 Global Necrotizing Fasciitis (NF) Treatment Breakdown Data by Application (2015-2026) 5.1 Global Necrotizing Fasciitis (NF) Treatment Historic Market Size by Application (2015-2020) 5.2 Necrotizing Fasciitis (NF) Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 6.2 Key Necrotizing Fasciitis (NF) Treatment Players Market Share in North America (2019-2020) 6.3 North America Necrotizing Fasciitis (NF) Treatment Market Size by Country 6.3.1 North America Necrotizing Fasciitis (NF) Treatment Sales by Country 6.3.2 North America Necrotizing Fasciitis (NF) Treatment Market Size Forecast by Country (2021-2026) 6.4 U.S. Market Size Analysis 6.4.1 U.S. Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 6.4.2 U.S. Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 6.4.3 U.S. Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 6.5 Canada Market Size Analysis 6.5.1 Canada Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 6.5.2 Canada Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 6.5.3 Canada Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 7 Europe 7.1 Europe Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 7.2 Key Necrotizing Fasciitis (NF) Treatment Players Market Share in Europe (2019-2020) 7.3 Europe Necrotizing Fasciitis (NF) Treatment Market Size by Country 7.3.1 Europe Necrotizing Fasciitis (NF) Treatment Sales by Country 7.3.2 Europe Necrotizing Fasciitis (NF) Treatment Market Size Forecast by Country (2021-2026) 7.4 Germany Market Size Analysis 7.4.1 Germany Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 7.4.2 Germany Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 7.4.3 Germany Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 7.5 France Market Size Analysis 7.5.1 France Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 7.5.2 France Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 7.5.3 France Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 7.6 U.K. Market Size Analysis 7.6.1 U.K. Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 7.6.2 U.K. Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 7.6.3 U.K. Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 7.7 Italy Market Size Analysis 7.7.1 Italy Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 7.7.2 Italy Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 7.7.3 Italy Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 7.8 Russia Market Size Analysis 7.8.1 Russia Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 7.8.2 Russia Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 7.8.3 Russia Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 8 Asia-Pacific 8.1 Asia-Pacific Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 8.2 Key Necrotizing Fasciitis (NF) Treatment Players Market Share in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Necrotizing Fasciitis (NF) Treatment Market Size by Country 8.3.1 Asia-Pacific Necrotizing Fasciitis (NF) Treatment Sales by Country 8.3.2 Asia-Pacific Necrotizing Fasciitis (NF) Treatment Market Size Forecast by Country (2021-2026) 8.4 China Market Size Analysis 8.4.1 China Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 8.4.2 China Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 8.4.3 China Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 8.5 Japan Market Size Analysis 8.5.1 Japan Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 8.5.2 Japan Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 8.5.3 Japan Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 8.6 South Korea Market Size Analysis 8.6.1 South Korea Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 8.6.2 South Korea Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 8.6.3 South Korea Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 8.7 India Market Size Analysis 8.7.1 India Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 8.7.2 India Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 8.7.3 India Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 8.8 Australia Market Size Analysis 8.8.1 Australia Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 8.8.2 Australia Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 8.8.3 Australia Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 8.9 Taiwan Market Size Analysis 8.9.1 Taiwan Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 8.9.2 Taiwan Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 8.9.3 Taiwan Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 8.10 Indonesia Market Size Analysis 8.10.1 Indonesia Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 8.10.2 Indonesia Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 8.10.3 Indonesia Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 8.11 Thailand Market Size Analysis 8.11.1 Thailand Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 8.11.2 Thailand Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 8.11.3 Thailand Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 8.12 Malaysia Market Size Analysis 8.12.1 Malaysia Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 8.12.2 Malaysia Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 8.12.3 Malaysia Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 8.13 Philippines Market Size Analysis 8.13.1 Philippines Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 8.13.2 Philippines Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 8.13.3 Philippines Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 8.14 Vietnam Market Size Analysis 8.14.1 Vietnam Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 8.14.2 Vietnam Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 8.14.3 Vietnam Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 9 Latin America 9.1 Latin America Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 9.2 Key Necrotizing Fasciitis (NF) Treatment Players Market Share in Latin America (2019-2020) 9.3 Latin America Necrotizing Fasciitis (NF) Treatment Market Size by Country 9.3.1 Latin America Necrotizing Fasciitis (NF) Treatment Sales by Country 9.3.2 Latin America Necrotizing Fasciitis (NF) Treatment Market Size Forecast by Country (2021-2026) 9.4 Mexico Market Size Analysis 9.4.1 Mexico Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 9.4.2 Mexico Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 9.4.3 Mexico Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 9.5 Brazil Market Size Analysis 9.5.1 Brazil Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 9.5.2 Brazil Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 9.5.3 Brazil Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 9.6 Argentina Market Size Analysis 9.6.1 Argentina Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 9.6.2 Argentina Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 9.6.3 Argentina Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 10 Middle East & Africa 10.1 Middle East & Africa Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 10.2 Key Necrotizing Fasciitis (NF) Treatment Players Market Share in Middle East & Africa (2019-2020) 10.3 Middle East & Africa Necrotizing Fasciitis (NF) Treatment Market Size by Country 10.3.1 Middle East & Africa Necrotizing Fasciitis (NF) Treatment Sales by Country 10.3.2 Middle East & Africa Necrotizing Fasciitis (NF) Treatment Market Size Forecast by Country (2021-2026) 10.4 Turkey Market Size Analysis 10.4.1 Turkey Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 10.4.2 Turkey Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 10.4.3 Turkey Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 10.5 Saudi Arabia Market Size Analysis 10.5.1 Saudi Arabia Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 10.5.2 Saudi Arabia Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 10.5.3 Saudi Arabia Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 10.6 UAE Market Size Analysis 10.6.1 UAE Necrotizing Fasciitis (NF) Treatment Market Size (2015-2026) 10.6.2 UAE Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2026) 10.6.3 UAE Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2026) 11 Company Profiles 11.1 Merck & Co., Inc. 11.1.1 Merck & Co., Inc. Company Details 11.1.2 Merck & Co., Inc. Business Overview and Its Total Revenue 11.1.3 Merck & Co., Inc. Introduction 11.1.4 Merck & Co., Inc. Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) 11.1.5 Merck & Co., Inc. Recent Development 11.2 Pfizer, Inc. 11.2.1 Pfizer, Inc. Company Details 11.2.2 Pfizer, Inc. Business Overview and Its Total Revenue 11.2.3 Pfizer, Inc. Introduction 11.2.4 Pfizer, Inc. Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) 11.2.5 Pfizer, Inc. Recent Development 11.3 GlaxoSmithKline plc 11.3.1 GlaxoSmithKline plc Company Details 11.3.2 GlaxoSmithKline plc Business Overview and Its Total Revenue 11.3.3 GlaxoSmithKline plc Introduction 11.3.4 GlaxoSmithKline plc Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) 11.3.5 GlaxoSmithKline plc Recent Development 11.4 Teva Pharmaceutical Industries Ltd. 11.4.1 Teva Pharmaceutical Industries Ltd. Company Details 11.4.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue 11.4.3 Teva Pharmaceutical Industries Ltd. Introduction 11.4.4 Teva Pharmaceutical Industries Ltd. Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) 11.4.5 Teva Pharmaceutical Industries Ltd. Recent Development 11.5 Bristol-Myers Squibb Company 11.5.1 Bristol-Myers Squibb Company Company Details 11.5.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue 11.5.3 Bristol-Myers Squibb Company Introduction 11.5.4 Bristol-Myers Squibb Company Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) 11.5.5 Bristol-Myers Squibb Company Recent Development 11.6 Abbott 11.6.1 Abbott Company Details 11.6.2 Abbott Business Overview and Its Total Revenue 11.6.3 Abbott Introduction 11.6.4 Abbott Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) 11.6.5 Abbott Recent Development 11.7 Wockhardt 11.7.1 Wockhardt Company Details 11.7.2 Wockhardt Business Overview and Its Total Revenue 11.7.3 Wockhardt Introduction 11.7.4 Wockhardt Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) 11.7.5 Wockhardt Recent Development 11.8 Atox Bio 11.8.1 Atox Bio Company Details 11.8.2 Atox Bio Business Overview and Its Total Revenue 11.8.3 Atox Bio Introduction 11.8.4 Atox Bio Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) 11.8.5 Atox Bio Recent Development 11.9 Melinta Therapeutics 11.9.1 Melinta Therapeutics Company Details 11.9.2 Melinta Therapeutics Business Overview and Its Total Revenue 11.9.3 Melinta Therapeutics Introduction 11.9.4 Melinta Therapeutics Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) 11.9.5 Melinta Therapeutics Recent Development 12 Analyst's Viewpoints/Conclusion 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer

List of Tables Table 1. Necrotizing Fasciitis (NF) Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Necrotizing Fasciitis (NF) Treatment Revenue Table 3. Ranking of Global Top Necrotizing Fasciitis (NF) Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Necrotizing Fasciitis (NF) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Penicillin G Table 6. Key Players of Clindamycin Table 7. Key Players of Aminoglycoside Table 8. Key Players of Carbapenem Table 9. Key Players of Metronidazole Table 10. Key Players of Fluoroconazoles Table 11. Key Players of Others Table 12. COVID-19 Impact Global Market: (Four Necrotizing Fasciitis (NF) Treatment Market Size Forecast Scenarios) Table 13. Opportunities and Trends for Necrotizing Fasciitis (NF) Treatment Players in the COVID-19 Landscape Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 15. Key Regions/Countries Measures against Covid-19 Impact Table 16. Proposal for Necrotizing Fasciitis (NF) Treatment Players to Combat Covid-19 Impact Table 17. Global Necrotizing Fasciitis (NF) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 18. Global Necrotizing Fasciitis (NF) Treatment Market Size by Region (US$ Million): 2020 VS 2026 Table 19. Global Necrotizing Fasciitis (NF) Treatment Market Size by Regions (2015-2020) (US$ Million) Table 20. Global Necrotizing Fasciitis (NF) Treatment Market Share by Regions (2015-2020) Table 21. Global Necrotizing Fasciitis (NF) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 22. Global Necrotizing Fasciitis (NF) Treatment Market Share by Regions (2021-2026) Table 23. Market Top Trends Table 24. Key Drivers: Impact Analysis Table 25. Key Challenges Table 26. Necrotizing Fasciitis (NF) Treatment Market Growth Strategy Table 27. Main Points Interviewed from Key Necrotizing Fasciitis (NF) Treatment Players Table 28. Global Necrotizing Fasciitis (NF) Treatment Revenue by Players (2015-2020) (US$ Million) Table 29. Global Necrotizing Fasciitis (NF) Treatment Market Share by Players (2015-2020) Table 30. Global Top Necrotizing Fasciitis (NF) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotizing Fasciitis (NF) Treatment as of 2019) Table 31. Global 5 Largest Players Market Share by Necrotizing Fasciitis (NF) Treatment Revenue (CR5 and HHI) (2015-2020) Table 32. Key Players Headquarters and Area Served Table 33. Key Players Necrotizing Fasciitis (NF) Treatment Product Solution and Service Table 34. Date of Enter into Necrotizing Fasciitis (NF) Treatment Market Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Necrotizing Fasciitis (NF) Treatment Market Size by Type (2015-2020) (US$ Million) Table 37. Global Necrotizing Fasciitis (NF) Treatment Revenue Market Share by Type (2015-2020) Table 38. Global Necrotizing Fasciitis (NF) Treatment Forecasted Market Size by Type (2021-2026) (US$ Million) Table 39. Global Necrotizing Fasciitis (NF) Treatment Revenue Market Share by Type (2021-2026) Table 40. Global Necrotizing Fasciitis (NF) Treatment Market Size by Application (2015-2020) (US$ Million) Table 41. Global Necrotizing Fasciitis (NF) Treatment Revenue Market Share by Application (2015-2020) Table 42. Global Necrotizing Fasciitis (NF) Treatment Forecasted Market Size by Application (2021-2026) (US$ Million) Table 43. Global Necrotizing Fasciitis (NF) Treatment Revenue Market Share by Application (2021-2026) Table 44. Key Players Necrotizing Fasciitis (NF) Treatment Revenue in North America (2019-2020) (US$ Million) Table 45. Key Players Necrotizing Fasciitis (NF) Treatment Market Share in North America (2019-2020) Table 46. North America Necrotizing Fasciitis (NF) Treatment Market Size by Countries (2015-2020) (US$ Million) Table 47. North America Necrotizing Fasciitis (NF) Treatment Market Size Share by Countries (2015-2020) Table 48. North America Necrotizing Fasciitis (NF) Treatment Market Size by Countries (2021-2026) (US$ Million) Table 49. North America Necrotizing Fasciitis (NF) Treatment Market Size Share by Countries (2021-2026) Table 50. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in U.S., Breakdown by Type (2015-2020) Table 51. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in U.S., Breakdown by Type (2021-2026) Table 52. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in U.S., Breakdown by Application (2015-2020) Table 53. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in U.S., Breakdown by Application (2021-2026) Table 54. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Canada, Breakdown by Type (2015-2020) Table 55. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Canada, Breakdown by Type (2021-2026) Table 56. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Canada, Breakdown by Application (2015-2020) Table 57. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Canada, Breakdown by Application (2021-2026) Table 58. Key Players Necrotizing Fasciitis (NF) Treatment Revenue in Europe (2019-2020) (US$ Million) Table 59. Key Players Necrotizing Fasciitis (NF) Treatment Market Share in Europe (2019-2020) Table 60. Europe Necrotizing Fasciitis (NF) Treatment Market Size by Countries (2015-2020) (US$ Million) Table 61. Europe Necrotizing Fasciitis (NF) Treatment Market Size Share by Countries (2015-2020) Table 62. Europe Necrotizing Fasciitis (NF) Treatment Market Size by Countries (2021-2026) (US$ Million) Table 63. Europe Necrotizing Fasciitis (NF) Treatment Market Size Share by Countries (2021-2026) Table 64. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Germany, Breakdown by Type (2015-2020) Table 65. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Germany, Breakdown by Type (2021-2026) Table 66. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Germany, Breakdown by Application (2015-2020) Table 67. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Germany, Breakdown by Application (2021-2026) Table 68. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in France, Breakdown by Type (2015-2020) Table 69. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in France, Breakdown by Type (2021-2026) Table 70. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in France, Breakdown by Application (2015-2020) Table 71. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in France, Breakdown by Application (2021-2026) Table 72. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in U.K., Breakdown by Type (2015-2020) Table 73. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in U.K., Breakdown by Type (2021-2026) Table 74. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in U.K., Breakdown by Application (2015-2020) Table 75. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in U.K., Breakdown by Application (2021-2026) Table 76. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Italy, Breakdown by Type (2015-2020) Table 77. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Italy, Breakdown by Type (2021-2026) Table 78. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Italy, Breakdown by Application (2015-2020) Table 79. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Italy, Breakdown by Application (2021-2026) Table 80. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Russia, Breakdown by Type (2015-2020) Table 81. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Russia, Breakdown by Type (2021-2026) Table 82. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Russia, Breakdown by Application (2015-2020) Table 83. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Russia, Breakdown by Application (2021-2026) Table 84. Key Players Necrotizing Fasciitis (NF) Treatment Revenue in Asia-Pacific (2019-2020) (US$ Million) Table 85. Key Players Necrotizing Fasciitis (NF) Treatment Market Share in Asia-Pacific (2019-2020) Table 86. Asia-Pacific Necrotizing Fasciitis (NF) Treatment Market Size by Regions (2015-2020) (US$ Million) Table 87. Asia-Pacific Necrotizing Fasciitis (NF) Treatment Market Size Share by Regions (2015-2020) Table 88. Asia-Pacific Necrotizing Fasciitis (NF) Treatment Market Size by Regions (2021-2026) (US$ Million) Table 89. Asia-Pacific Necrotizing Fasciitis (NF) Treatment Market Size Share by Regions (2021-2026) Table 90. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in China, Breakdown by Type (2015-2020) Table 91. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in China, Breakdown by Type (2021-2026) Table 92. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in China, Breakdown by Application (2015-2020) Table 93. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in China, Breakdown by Application (2021-2026) Table 94. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Japan, Breakdown by Type (2015-2020) Table 95. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Japan, Breakdown by Type (2021-2026) Table 96. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Japan, Breakdown by Application (2015-2020) Table 97. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Japan, Breakdown by Application (2021-2026) Table 98. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in South Korea, Breakdown by Type (2015-2020) Table 99. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in South Korea, Breakdown by Type (2021-2026) Table 100. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in South Korea, Breakdown by Application (2015-2020) Table 101. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in South Korea, Breakdown by Application (2021-2026) Table 102. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in India, Breakdown by Type (2015-2020) Table 103. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in India, Breakdown by Type (2021-2026) Table 104. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in India, Breakdown by Application (2015-2020) Table 105. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in India, Breakdown by Application (2021-2026) Table 106. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Australia, Breakdown by Type (2015-2020) Table 107. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Australia, Breakdown by Type (2021-2026) Table 108. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Australia, Breakdown by Application (2015-2020) Table 109. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Australia, Breakdown by Application (2021-2026) Table 110. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Taiwan, Breakdown by Type (2015-2020) Table 111. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Taiwan, Breakdown by Type (2021-2026) Table 112. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Taiwan, Breakdown by Application (2015-2020) Table 113. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Taiwan, Breakdown by Application (2021-2026) Table 114. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Indonesia, Breakdown by Type (2015-2020) Table 115. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Indonesia, Breakdown by Type (2021-2026) Table 116. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Indonesia, Breakdown by Application (2015-2020) Table 117. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Indonesia, Breakdown by Application (2021-2026) Table 118. Key Players Necrotizing Fasciitis (NF) Treatment Revenue in Latin America (2019-2020) (US$ Million) Table 119. Key Players Necrotizing Fasciitis (NF) Treatment Market Share in Latin America (2019-2020) Table 120. Latin America Necrotizing Fasciitis (NF) Treatment Market Size by Countries (2015-2020) (US$ Million) Table 121. Latin America Necrotizing Fasciitis (NF) Treatment Market Size Share by Countries (2015-2020) Table 122. Latin America Necrotizing Fasciitis (NF) Treatment Market Size by Countries (2021-2026) (US$ Million) Table 123. Latin America Necrotizing Fasciitis (NF) Treatment Market Size Share by Countries (2021-2026) Table 124. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Mexico, Breakdown by Type (2015-2020) Table 125. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Mexico, Breakdown by Type (2021-2026) Table 126. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Mexico, Breakdown by Application (2015-2020) Table 127. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Mexico, Breakdown by Application (2021-2026) Table 128. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Brazil, Breakdown by Type (2015-2020) Table 129. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Brazil, Breakdown by Type (2021-2026) Table 130. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Brazil, Breakdown by Application (2015-2020) Table 131. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Brazil, Breakdown by Application (2021-2026) Table 132. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Argentina, Breakdown by Type (2015-2020) Table 133. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Argentina, Breakdown by Type (2021-2026) Table 134. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Argentina, Breakdown by Application (2015-2020) Table 135. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Argentina, Breakdown by Application (2021-2026) Table 136. Key Players Necrotizing Fasciitis (NF) Treatment Revenue in Middle East & Africa (2019-2020) (US$ Million) Table 137. Key Players Necrotizing Fasciitis (NF) Treatment Market Share in Middle East & Africa (2019-2020) Table 138. Middle East & Africa Necrotizing Fasciitis (NF) Treatment Market Size by Countries (2015-2020) (US$ Million) Table 139. Middle East & Africa Necrotizing Fasciitis (NF) Treatment Market Size Share by Countries (2015-2020) Table 140. Middle East & Africa Necrotizing Fasciitis (NF) Treatment Market Size by Countries (2021-2026) (US$ Million) Table 141. Middle East & Africa Necrotizing Fasciitis (NF) Treatment Market Size Share by Countries (2021-2026) Table 142. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Turkey, Breakdown by Type (2015-2020) Table 143. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Turkey, Breakdown by Type (2021-2026) Table 144. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Turkey, Breakdown by Application (2015-2020) Table 145. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Turkey, Breakdown by Application (2021-2026) Table 146. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2015-2020) Table 147. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2021-2026) Table 148. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2015-2020) Table 149. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2021-2026) Table 150. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in UAE, Breakdown by Type (2015-2020) Table 151. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in UAE, Breakdown by Type (2021-2026) Table 152. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in UAE, Breakdown by Application (2015-2020) Table 153. Necrotizing Fasciitis (NF) Treatment Market Size (US$ Million) in UAE, Breakdown by Application (2021-2026) Table 154. Merck & Co., Inc. Company Details Table 155. Merck & Co., Inc. Business Overview Table 156. Merck & Co., Inc. Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) (US$ Million) Table 157. Merck & Co., Inc. Product Table 158. Merck & Co., Inc. Recent Development Table 159. Pfizer, Inc. Company Details Table 160. Pfizer, Inc. Business Overview Table 161. Pfizer, Inc. Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) (US$ Million) Table 162. Pfizer, Inc. Product Table 163. Pfizer, Inc. Recent Development Table 164. GlaxoSmithKline plc Company Details Table 165. GlaxoSmithKline plc Business Overview Table 166. GlaxoSmithKline plc Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) (US$ Million) Table 167. GlaxoSmithKline plc Product Table 168. GlaxoSmithKline plc Recent Development Table 169. Teva Pharmaceutical Industries Ltd. Company Details Table 170. Teva Pharmaceutical Industries Ltd. Business Overview Table 171. Teva Pharmaceutical Industries Ltd. Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) (US$ Million) Table 172. Teva Pharmaceutical Industries Ltd. Product Table 173. Teva Pharmaceutical Industries Ltd. Recent Development Table 174. Bristol-Myers Squibb Company Company Details Table 175. Bristol-Myers Squibb Company Business Overview Table 176. Bristol-Myers Squibb Company Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) (US$ Million) Table 177. Bristol-Myers Squibb Company Product Table 178. Bristol-Myers Squibb Company Recent Development Table 179. Abbott Company Details Table 180. Abbott Business Overview Table 181. Abbott Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) (US$ Million) Table 182. Abbott Product Table 183. Abbott Recent Development Table 184. Wockhardt Company Details Table 185. Wockhardt Business Overview Table 186. Wockhardt Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) (US$ Million) Table 187. Wockhardt Product Table 188. Wockhardt Recent Development Table 189. Atox Bio Company Details Table 190. Atox Bio Business Overview Table 191. Atox Bio Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) (US$ Million) Table 192. Atox Bio Product Table 193. Atox Bio Recent Development Table 194. Melinta Therapeutics Company Details Table 195. Melinta Therapeutics Business Overview Table 196. Melinta Therapeutics Revenue in Necrotizing Fasciitis (NF) Treatment Business (2015-2020) (US$ Million) Table 197. Melinta Therapeutics Product Table 198. Melinta Therapeutics Recent Development Table 199. Research Programs/Design for This Report Table 200. Key Data Information from Secondary Sources Table 201. Key Data Information from Primary Sources List of Figures Figure 1. Global Necrotizing Fasciitis (NF) Treatment Market Share by Type in 2020 & 2026 Figure 2. Penicillin G Features Figure 3. Clindamycin Features Figure 4. Aminoglycoside Features Figure 5. Carbapenem Features Figure 6. Metronidazole Features Figure 7. Fluoroconazoles Features Figure 8. Others Features Figure 9. Global Necrotizing Fasciitis (NF) Treatment Market Share by Application in 2020 & 2026 Figure 10. Hospital Pharmacies Case Studies Figure 11. Retail Pharmacies Case Studies Figure 12. Online Pharmacies Case Studies Figure 13. Others Case Studies Figure 14. Necrotizing Fasciitis (NF) Treatment Report Years Considered Figure 15. Global Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 16. Global Necrotizing Fasciitis (NF) Treatment Market Share by Regions: 2020 VS 2026 Figure 17. Global Necrotizing Fasciitis (NF) Treatment Market Share by Regions (2021-2026) Figure 18. Porter's Five Forces Analysis Figure 19. Global Necrotizing Fasciitis (NF) Treatment Market Share by Players in 2019 Figure 20. Global Top Necrotizing Fasciitis (NF) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotizing Fasciitis (NF) Treatment as of 2019) Figure 21. The Top 10 and 5 Players Market Share by Necrotizing Fasciitis (NF) Treatment Revenue in 2019 Figure 22. North America Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 23. U.S. Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 24. Canada Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 25. Europe Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 26. Germany Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 27. France Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 28. U.K. Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 29. Italy Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 30. Russia Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 31. Asia-Pacific Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 32. China Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 33. Japan Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 34. South Korea Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 35. India Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 36. Australia Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 37. Taiwan Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 38. Indonesia Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 39. Thailand Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 40. Malaysia Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 41. Philippines Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 42. Vietnam Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 43. Latin America Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 44. Mexico Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 45. Brazil Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 46. Argentina Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 47. Middle East & Africa Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 48. Turkey Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 49. Saudi Arabia Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 50. UAE Necrotizing Fasciitis (NF) Treatment Market Size YoY Growth (2015-2026) (US$ Million) Figure 51. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 53. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 55. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 56. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 57. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018 Figure 58. Atox Bio Total Revenue (US$ Million): 2019 Compared with 2018 Figure 59. Melinta Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation

Merck & Co., Inc. Pfizer, Inc. GlaxoSmithKline plc Teva Pharmaceutical Industries Ltd. Bristol-Myers Squibb Company Abbott Wockhardt Atox Bio Melinta Therapeutics